Why Investors Need to Bet on This 1 Cannabis Stock

Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock is on the verge of a breakout. It has burnt significant investor wealth in the last 10 months. Aurora investors have lost over 37% since October 2018. Several cannabis stocks were overvalued at the end of last year, just before Canada regularized marijuana for recreational purposes.

After that euphoria died down, cannabis stocks fell significantly. Shares of peer companies such as Canopy Growth, Tilray, and Aphria have lost 41%, 74%, and 52%, respectively, since the start of October 2018. So, will Aurora shares move higher in the coming months?

Aurora Cannabis has gained 312% since IPO

Despite the pullback starting last October, Aurora shares have gained 312% since its IPO back in October 2016. This means Aurora stock rose by a stellar 550% between October 2016 and 2018. While there have been regulatory issues plaguing cannabis companies of late, their growth story remains far from over.

The cannabis industry is still in the nascent stage of growth. Statista estimates the global legal cannabis spending to reach $63.5 billion in 2024, up from $24.4 billion in 2019. This indicates a compound annual growth rate of 21%. Aurora Cannabis will at the forefront of this growth. It will, in fact, easily outpace market growth in the coming years.

Analysts expect Aurora Cannabis sales to rise by 370% to $259.4 million in 2019, 174% to $710 million in 2020, and 74% to $1.21 billion in 2021.

Aurora expected to release fourth-quarter earnings next month

Aurora Cannabis is expected to release its fiscal fourth-quarter 2019 results (quarter ended in June) on September 15. Last week, the company released preliminary results and estimated sales between $100 million and $107 million for the fourth quarter. This is slightly lower than analyst sales estimates of $108.7 million.

In case Aurora reports sales of $104 million (its midpoint estimate) in Q4 2019, it will mean a year-over-year growth of 443%. Aurora estimated 2019 sales of $250 million, a rise of 353% year over year.

Key drivers for Aurora Cannabis stock

Aurora is banking on international expansion to drive revenue growth. Aurora products are available in 25 countries, and the company already leads the European and Latin American markets in the medical cannabis segment.

Its inorganic growth via acquisitions has resulted in an increase in production capacities by four times. Aurora has acquired 18 companies in the last two years. Its production capacity is expected to increase from 150,000 kilograms per year in 2019 to 625,000 kilograms per year in 2020.

Aurora Cannabis has estimated the total addressable market at $200 billion. The company has valued the Canadian medical cannabis market at $3 billion and the global medical cannabis market at $70 billion. The Canadian consumer market is valued at $9 billion, while the global consumer market is valued at $115 billion.

There are concerns over Aurora’s cash burn. Bank of America is worried over Aurora’s cash outflow and downgraded the stock from “buy” to “neutral.” Aurora’s bottom line is estimated to fall by 46% in 2019. High-growth companies need to invest heavily in capital expenditure, acquisitions, and product marketing, all of which has been undertaken by Aurora’s management.

However, there will be a significant improvement in profit margins going forward. Aurora’s net margin is estimated to improve from -16% in 2020 to 6.5% in 2021. A high-growth, profitable company is a dream for investors.  This growth trajectory could result in massive returns for shareholders.

Analysts have a 12-month average target price of $13.55 for Aurora Cannabis, indicating an upside potential of 55% from the current price.

You might be missing out on one of the biggest opportunities in Canadian investing history…

Marijuana was legalized across Canada on October 17th, and a little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

Besides making key partnerships with Facebook and Amazon, they’ve just made a game-changing deal with the Ontario government.

This is the company we think you should strongly consider having in your portfolio if you want to position yourself wisely for the coming marijuana boom.

Learn More About This TSX Stock Now

More reading

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

Source: The Fool
Why Investors Need to Bet on This 1 Cannabis Stock
The Fool

The Motley Fool
Contributor for investorsnews.ca
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related posts